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Respiratory epithelial cells are derived from cell progenitors in the foregut endoderm that subsequently
differentiate into the distinct cell types lining the conducting and alveolar regions of the lung.
To identify transcriptional mechanisms regulating differentiation and maintenance of respiratory
epithelial cells, we conditionally deleted Foxm1 transcription factor from the conducting airways of
the developing mouse lung. Conditional deletion of Foxm1 from Clara cells, controlled by the Scgb1a1
promoter, dramatically altered airway structure and caused peribronchial ﬁbrosis, resulting in airway
hyperreactivity in adult mice. Deletion of Foxm1 inhibited proliferation of Clara cells and disrupted the
normal patterning of epithelial cell differentiation in the bronchioles, causing squamous and goblet cell
metaplasia, and the loss of Clara and ciliated cells. Surprisingly, conducting airways of Foxm1-deﬁcient
mice contained highly differentiated cuboidal type II epithelial cells that are normally restricted to the
alveoli. Lineage tracing studies showed that the ectopic alveolar type II cells in Foxm1-deﬁcient airways
were derived from Clara cells. Deletion of Foxm1 inhibited Sox2 and Scgb1a1, both of which are critical
for differentiation and function of Clara cells. In co-transfection experiments, Foxm1 directly bound to
and induced transcriptional activity of Scgb1a1 and Sox2 promoters. Foxm1 is required for differentia-
tion and maintenance of epithelial cells lining conducting airways.
& 2012 Elsevier Inc. All rights reserved.Introduction
The respiratory epithelium is derived from progenitor cells
from the foregut endoderm. Respiratory tubules subsequently
undergo branching morphogenesis, and epithelial cells differenti-
ate into the multiple speciﬁc cell types that line the conducting
airways and alveoli (Cardoso, 2001; Hogan and Yingling, 1998;
Morrisey and Hogan, 2010; Warburton et al., 1999; Whitsett
et al., 2004). Depending on species, composition of conducting
airways as compared to alveolar regions of the lung are ﬁrmly
established in the perinatal and early postnatal period of devel-
opment. The respiratory epithelium remains proliferative until
maturity as progenitor cells produce the complex pseudostratiﬁed
epithelium lining cartilagenous airways and the simple columnar
epithelium lining the bronchioles. While trachea and bronchi
contain ciliated, basal, goblet, and secretory or Clara cells, pul-
monary bronchioles are lined primarily by ciliated and Clara cells.
Alveolar regions of the lung are lined by type II and type Ill rights reserved.
iology, Cincinnati Children’s
7009, Cincinnati, OH 45229,
(V.V. Kalinichenko).epithelial cells. During lung morphogenesis and after lung injury,
Clara cells and basal cells serve as airway progenitor cells that
proliferate and re-differentiate to produce multiple airway
epithelial cell types (Li et al., 2008; Morrisey and Hogan, 2010;
Perl et al., 2005; Rawlins et al., 2009; Rock et al., 2011, 2009).
Abnormalities in airway epithelial cell differentiation are asso-
ciated with various lung disorders, including chronic obstructive
pulmonary diseases, asthma, cystic ﬁbrosis, interstitial lung dis-
ease and lung cancer (Warburton et al., 2010; Whitsett et al.,
2004). Signaling pathways and transcriptional networks that
control epithelial cell differentiation and the proximal/peripheral
patterning of the developing lung have been increasingly studied.
Signaling via FGF, Wnt, Bmp and Notch, and the activity of
transcription factors of multiple families including SOX, FOX,
NKX, ETS, RAR, and KLF families, all play important roles in the
differentiation of the respiratory epithelium (Cardoso, 2001;
Costa et al., 2001; Kalinichenko et al., 2001; Kim et al., 2005b;
Morrisey and Hogan, 2010; Warburton et al., 1999; Whitsett
et al., 2004). Lineage-tracing studies demonstrated that respira-
tory epithelial cell lineages speciﬁc to proximal (airway epithelial)
as compared to distal (alveolar epithelial) cell fate are established
relatively early in lung development, occurring well before the
formation of deﬁnitive lung buds (E6.5–E8.5) (Perl et al., 2002).
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and retain cell fate decisions later in development and during
repair have not been fully elucidated, Clara cells retain the ability
to be re-programmed to other airway epithelial cell fates even
after differentiation. Recent studies demonstrated a critical role of
SOX2 and SPDEF that are required for Clara/ciliated and Clara/
goblet cell differentiation, respectively (Chen et al., 2009; Que
et al., 2009; Tompkins et al., 2009). Whether airway Clara cells
retain the ability to differentiate into alveolar type I and type II
cells remains unknown.
The FOX family of proteins plays important roles in lung
morphogenesis and respiratory epithelial cell differentiation (Costa
et al., 2001; Kalin et al., 2011; Maeda et al., 2007; Morrisey and
Hogan, 2010). Foxa1 and Foxa2 are expressed throughout the
respiratory epithelium (Besnard et al., 2004) and have partially
redundant functions during early lung formation being required for
normal branching morphogenesis and epithelial cell differentiation
(Maeda et al., 2007; Morrisey and Hogan, 2010; Wan et al., 2004).
Later in development, expression of other Fox proteins become
more restricted, Foxj1 playing a critical role in ciliagenesis (Brody
et al., 2000) and Foxa3 marking a subset of goblet cells in conducting
airways (Chen et al., 2009). Foxp2 is required for postnatal lung
alveolarization (Shu et al., 2007). Mice haploinsufﬁcient for Foxf1
exhibited lung hypoplasia, defects in peribronchial smooth muscle
and alveolar capillaries, and increased mortality in the early neona-
tal period (Kalinichenko et al., 2004a,, 2001,, 2002). Genomic
mutations in FoxF1 gene locus were recently found in 30% of human
patients with Alveolar Capillary Dysplasia (ACD), a congenital lethal
lung disease (Stankiewicz et al., 2009).
Foxm1 transcription factor (previously known as HFH-11B,
Trident, Win, or MPP2) is expressed in various tissues during
embryogenesis, but is restricted to intestinal crypts, thymus, testes,
regenerating tissues and malignancies in adult tissues (Kalin et al.,
2011; Korver et al., 1997; Ye et al., 1997). Foxm1/ mouse embryos
exhibited embryonic lethal phenotype between E13.5 and E16.5 due
to multiple abnormalities in various organ systems, including liver,
lungs, blood vessels, and heart (Bolte et al., 2011; Kim et al., 2005b;
Krupczak-Hollis et al., 2004; Ramakrishna et al., 2007). Abnormal
accumulation of polyploid cardiomyocytes and hepatoblasts was
found in Foxm1/ embryos, implicating Foxm1 in the cell cycle
regulation (Krupczak-Hollis et al., 2004; Ramakrishna et al., 2007).
Majority of mice with smooth muscle-speciﬁc Foxm1 deletion
(smMHC-Cre Foxm1ﬂ/ﬂ) died immediately after birth due to severe
pulmonary hemorrhage, structural defects in arterial wall, and
esophageal abnormalities (Ustiyan et al., 2009). Deletion of Foxm1
from alveolar epithelium (SPC-rtTA/TetO-Cre Foxm1ﬂ/ﬂ) caused
respiratory failure after birth due to impaired lung maturation,
delayed differentiation of type I and type II alveolar epithelial cells
and decreased expression of surfactant-associated proteins SP-B and
SP-C (Kalin et al., 2008). Deletion of Foxm1 from alveolar type II cells
impaired alveolar barrier repair after injury (Liu et al., 2011) and
inhibited chemically-induced lung carcinogenesis (Wang et al.,
2009). Although these studies demonstrated that Foxm1 is a critical
transcriptional regulator of alveolar epithelial cells, the role of
Foxm1 in the airway epithelium has not been identiﬁed.Materials and methods
Mice
Animal studies were reviewed and approved by the Animal
Care and Use Committee of Cincinnati Children’s Hospital
Research Foundation. Generation of Foxm1ﬂox/ﬂox (Foxm1ﬂ/ﬂ)
mouse line, which contains LoxP sequences ﬂanking DNA bindingand transcriptional activation domains of the Foxm1 gene (exons
4–7), was previously described (Krupczak-Hollis et al., 2004).
The Foxm1ﬂ/ﬂ mice were bred with CCSP–rtTAtg//TetO-Cretg/tg
mice (line 2, (Chen et al., 2009)) to generate CCSP–rtTAtg//TetO-
Cretg//Foxm1ﬂ/ﬂ mice. Doxycycline (625 mg/kg; Harlan Teklad,
Madison, WI) was administered to the dams in the food starting
at E16.5. Dox treatment continued until P5 or P30, causing
conditional deletion of Foxm1 in Clara cells and their derivatives
herein termed CCSP-Foxm1/ mice. Less than 0.5% of distal
epithelial cells expressed Cre protein at either P5 or P30. In
separate experiments, Dox was given to adult (6–8 weeks old)
mice for either 2 weeks or 5 months. Foxm1ﬂ/ﬂ littermates lacking
either the CCSP–rtTA, the TetO-Cre or both transgenes were used as
controls. Further controls included Dox-treated CCSP–rtTAtg//
TetO-Cretg//Foxm1wt/wt mice as well as CCSP–rtTAtg//TetO-Cretg/
/Foxm1ﬂ/ﬂ mice without Dox treatment. Airway structure and
function in control mice were normal. For lineage-tracing experi-
ments, the mice were bred with R26R reporter mice (Rosa26-LoxP-
stop-LoxP-b-galactosidase; Jackson Lab).
To induce lung injury, 6–8 week old CCSP–rtTAtg//TetO-Cretg//
Foxm1ﬂ/ﬂ and Foxm1ﬂ/ﬂ male mice were treated with naphthalene
(Sigma-Aldrich, 275 mg/kg as a single intraperitoneal injection) as
described (Kida et al., 2008). Dox was given for 7 day prior to lung
injury. Mice were sacriﬁced at days 0, 5 and 14 after naphthalene
administration.
Immunohistochemical staining
Embryos were harvested, ﬁxed in 10% buffered formalin, and
embedded into parafﬁn blocks. Five-mm sections were either
stained with hematoxylin and eosin (H&E) for morphological
examination or used for immunohistochemistry as described
(Kalin et al., 2008). The following antibodies were used for
immunostaining: Foxm1 (1:1000, K-19, sc500, Santa Cruz Bio-
technology); Cre recombinase (1:15000, #69050-3, Novagen);
CCSP (1:5000, T-18, sc9772, Santa Cruz Biotechnology and
1:2000, WRAB-CCSP, Seven Hill Bioreagents); Foxj1 (1:1000,
WMAB-319, Seven Hill Bioreagents); Ki-67 (1:500, clone Tec-3,
Dako); PH3 (1:500, sc8656r, Santa Cruz Biotechnology); proSP-C
(1:2000, (Kalin et al., 2008)); mature SP-C (1:1000, WRAB-MSPC,
Seven Hill Bioreagents); mature SP-B (1:1500, generated in lab of
Kalin et al. (2008)); ABCA3 (1:500, sc5361, Santa Cruz Biotech-
nology); T1a (1:500, DSHB 8.1.1., University of Iowa Hybridoma
bank); TTF-1 (1:2000, WRAB-TTF1, Seven Hill Bioreagents); Foxa2
(1:4000, WRAB-FoxA2, Seven Hills Bioreagents); Foxa3 (1:200,
sc5361, Santa Cruz Biotechnology); b-tubulin (1:100, MU178-UC,
BioGenex); SPDEF (1:2000, generated in lab of Chen et al. (2009));
a-Smooth muscle actin (aSMA, 1:10000, clone A5228, Sigma); b-
galactosidase (1:1000, ab9361, Abcam); Mucin5AC (1:100, 45M1,
ab3649, Abcam); Sox2 (1:2500, generated in lab of Tompkins
et al., 2009); p63 (1:500, sc71827, Santa Cruz Biotechnology);
Cytokeratin 5 (1:3000, generated in lab of J. A. Whitsett); pan-
Cytokeratin (1:500, C1801, Sigma); Scgb3a1 (1:1000, sc49566,
Santa Cruz Biotechnology); b-catenin (1:500, sc7199, Santa Cruz
Biotechnology); E-cadherin (1:100, sc1499, Santa Cruz Biotechnol-
ogy). Antibody–antigen complexes were detected using biotiny-
lated secondary antibody followed by avidin–biotin-horseradish
peroxidase complex (ABC), and DAB substrate (all from Vector Lab).
Sections were counterstained with nuclear fast red (Vector Labs,
Burlingame, CA).
For co-localization experiments, secondary antibodies conju-
gated with alexaFluor 488 or alexaFluor 594 (Invitrogen/Molecu-
lar probes) were used as previously described (Ustiyan et al.,
2009; Wang et al., 2010). Slides were counterstained with DAPI
(Vector Lab). Fluorescent images were obtained using a Zeiss
Axioplan2 microscope equipped with an AxioCam MRm digital
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Thornwood, NY).
Transmission electron microscopy
For ultrastructural analysis, P30 lungs from Dox-treated CCSP-
Foxm1/ mice and littermate controls were ﬁxed in modiﬁed
Karnovsky’s ﬁxative (2% glutaraldehyde, 2% paraformaldehyde and
0.1% calcium chloride in 0.1 M sodium cacodylate buffer; pH 7.3).
The tissue was postﬁxed in 1% osmium tetroxide, stained with 4%
aqueous uranyl acetate (UA), dehydrated, and embedded in epoxy
resin (EMbed 812; Electron Microscopy Sciences, Fort Washington,
PA). Ultrathin sections were post-stained with 2% UA and saturated
lead citrate and viewed in a Hitachi H-7600 transmission electron
microscope (Hitachi, Ltd., Tokyo, Japan). Digitized images were
collected with an AMT Advantage Plus 2K2K digital camera
(Advanced Microscopy Techniques, Danvers, MA).
Lung mechanics and measurements of saturated PC
Lung mechanics was assessed on tracheostomized 8-week old
CCSP-Foxm1/ and control mice (5 mice for each group) using a
computerized Flexi Vent system (SCIREQ, Montreal, Canada) as
described (Xu et al., 2009). Saturated phosphatidylcholine (Sat PC)
was isolated from bronchoalveolar lavage ﬂuid (BALF) or lung
tissue homogenates using osmium tetroxide followed by mea-
surement of phosphorus as described (Xu et al., 2009).
Quantitative real-time RT-PCR (qRT-PCR)
Lungs from CCSP-Foxm1/ or control Foxm1ﬂ/ﬂ mice were
used to prepare total RNA and analyze gene expression by
qRT-PCR. StepOnePlus Real-Time PCR system (Applied Biosys-
tems, Foster City, CA) was used as described (Kalin et al., 2008).
Samples were ampliﬁed with TaqMan Gene Expression Master
Mix (Applied Biosystems) combined with inventoried TaqMan
gene expression assays for the gene of interest (Suppl. Table 1).
Reactions were analyzed in triplicates. Expression levels were
normalized to b-actin mRNA from the same samples.
Cotransfection studies
U2OS cells were transfected with either CMV-FoxM1b or control
CMV-empty plasmids, as well as with luciferase (LUC) reporters
driven by either 2.3 kb mouse CCSP promoter (Scgb1a1) or
5.7 kb mouse Sox2 promoter. CMV-Renilla was used as an
internal control to normalize transfection efﬁciency. Dual luciferase
assay (Promega) was performed as described (Kalin et al., 2008).
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed using in situ cross-linked human
bronchial epithelial BEAS-2B cells as described (Kalin et al., 2008;
Malin et al., 2007; Wang et al., 2005). Antibodies used for ChIP:
rabbit anti-Foxm1 Ab#1 (H-300, Santa Cruz), rabbit anti-Foxm1
Ab#2 (C-20, Santa Cruz) and control rabbit IgG (Vector Lab). The
following sense (S) and antisense (AS) PCR primers were used to
amplify promoter DNA fragments in ChIP assay: human Scgb1a1
(S) 50-AATTTTATTCTTTA-30 and (AS) 50-ATGTTGAATAAAA-30; human
Sox2 (S) 50-AAAAAAATATGATTA-30 and (AS) 50-TTAATTTTTATAA-30.
Statistical analysis
Student’s T-test was used to determine statistical signiﬁcance.
P valuesr0.05 were considered signiﬁcant. Values for all mea-
surements were expressed as the mean7standard deviation (SD).Results
Conditional deletion of Foxm1 from Clara cells
Previous studies demonstrated that expression of Foxm1
transcription factor is transiently increased in the respiratory
epithelium during the ﬁrst week after birth, during which its
expression is associated with increased proliferation of airway
epithelial cells (Wang et al., 2010). To determine whether Foxm1
is critical for proliferation of airway epithelial cells, transgenic
mice were produced containing Scgb1a1(CCSP)–rtTAtg/ and
TetO–Cretg/ transgenes, as well as the Foxm1ﬂ/ﬂ targeted allele
(Krupczak-Hollis et al., 2004) in which loxP sites were inserted
into exons 4–7 of the Foxm1 gene (Scgb1a1–rtTAtg//TetO–Cretg//
Foxm1ﬂ/ﬂ or CCSP-Foxm1ﬂ/ﬂ mice). Scgb1a1 mouse (line 2) selec-
tively expresses the reverse tetracycline transactivator (rtTA) in
the majority of Clara cells without targeting other cell types in the
lung (Chen et al., 2009). In the presence of doxycycline (Dox),
rtTA binds to the TetO promoter and induces expression of Cre
recombinase, deleting the DNA binding and transcriptional acti-
vation domains of the FOXM1 protein (Suppl. Fig. 1A) and
causing selective deletion of Foxm1 from airway Clara cells
(CCSP-Foxm1ﬂ/ﬂþDox herein termed CCSP-Foxm1/ mice).
Reduced proliferation of Clara cells in CCSP-Foxm1 / mice
To address the efﬁciency of Foxm1 deletion and examine
proliferation of Clara cells during the postnatal period, CCSP-
Foxm1/ and control mice (Foxm1ﬂ/ﬂ and TetO-Cre Foxm1ﬂ/ﬂ)
were given Dox-loaded food at E16.5 (after this Dox regimen, the
ﬁrst Cre-expressing cells are found between E18.5 and postnatal
day 1 (P1)). Mice were harvested at P5 to assess the Foxm1
deletion. Foxm1 was readily detected in most airway epithelial
cells of control mice (Fig. 1B). Consistent with previous studies
(Chen et al., 2009), Cre was detected in the nuclei of airway
epithelial cells of CCSP-Foxm1/ mice after treatment with Dox,
and was absent from the bronchiolar epithelium of control mice
(Fig. 1A). Total numbers of Foxm1-positive epithelial cells were
dramatically decreased in CCSP-Foxm1/ airways (Fig. 1B and
1E), consistent with efﬁcient deletion of Foxm1 by the Cre
recombinase. Immunostaining for proliferation-speciﬁc Ki-67
antigen and phosphorylated histone H3 (PH3) was reduced
(Fig. 1C and D), and total numbers of epithelial cells undergoing
the cell cycle were signiﬁcantly decreased in CCSP-Foxm1/
airways compared to the bronchiolar epithelium of control mice
(Fig. 1F and G). Percentages of proliferative Clara cells were
signiﬁcantly decreased as demonstrated by co-localization
experiments between Ki-67 and CCSP (Fig. 1I and J). The number
of proliferative cells in distal lung saccules was unchanged
(Fig. 1H). Thus, Foxm1 deletion reduced proliferation of airway
Clara cells during the early postnatal period of lung development.
Deletion of Foxm1 decreased numbers of epithelial cells and caused
squamous metaplasia
Previous studies demonstrated that Clara cells are important
progenitor cells in conducting airways, being capable of cell
renewal and differentiation into other airway epithelial cell types
(Rawlins et al., 2009). Effects of Foxm1 deletion on differentiation
of airway epithelial cells were assessed in CCSP-Foxm1/ mice
treated with Dox from E16.5 to P30. At this age, lung development
is completed and airway structure ﬁrmly established. Body
weight was similar in CCSP-Foxm1/ and control mice (Suppl.
Fig. 1C). Lung mechanics, including airway elastance, pulmonary
compliance and tissue damping were not altered (Suppl. Fig. 1C).
While deletion of Foxm1 from Clara cells did not inﬂuence
Fig. 1. Efﬁcient Foxm1 deletion and reduced proliferation of epithelial cells in CCSP-Foxm1 / airways. (A–D), Foxm1 deletion from Clara cells reduces epithelial
proliferation in P5 lungs. CCSP-Foxm1/ and control Foxm1ﬂ/ﬂ and TetO-Cre/Foxm1ﬂ/ﬂ mice were treated with Dox at E16.5 and harvested at P5. Lung sections were stained
with antibodies against Cre, Foxm1, Ki-67 and phosphorylated histone 3 (PH3). Sections were counterstained with nuclear fast red. (E–H), Decreased numbers of epithelial
cells expressing Foxm1 (E), Ki-67 (F) and PH3 (G) in CCSP-Foxm1/ bronchioles (Br). Numbers of Foxm1-positive, Ki-67-positive and PH3-positive bronchiolar epithelial
cells (per 1 mm of airway length) were counted using ten random 400 ﬁelds (5 mice in each group). The number of PH3-positive cells was not altered in distal lung
regions (H). (I–J), Co-localization of CCSP (green) and Ki-67 (red) was performed in lung sections of P5 mice. DAPI was used to stain cell nuclei (blue). Ki-67-positive Clara
cells were counted in 10 random microscope ﬁelds of 3 distinct mice (J). Percentages of cells are presented as mean7S.D. (po0.05 is shown as n). Magniﬁcation: (A–D),
100 and 400 (insets); I, 630.
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Fig. 2. Decreased numbers of ciliated and Clara cells and the presence of squamous, goblet, and alveolar type II cells in airway epithelium of CCSP-Foxm1 / mice. (A–F),
CCSP- Foxm1/ and Foxm1ﬂ/ﬂ mice were treated with Dox from E16.5 to P30. Lung sections were stained with H&E (A) or used for immunohistochemistry (B–F). Slides
were counterstained with nuclear fast red. Arrows show positive staining in CCSP-Foxm1 / bronchioles (Br). (G–H), Distribution of epithelial cells in CCSP-Foxm1/ and
Foxm1ﬂ/ﬂ bronchioles. Numbers of cells per 1 mm of bronchioles were counted using immunostained lung sections. Ten random 400 microscope ﬁelds were used.
Mean7S.D. was determined using 5 mice in each group. A p valueo0.001 is shown with asterisks (*). Magniﬁcation: (A–F), 50; all inserts, 400.
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Fig. 3. Presence of squamous and type II cells in bronchiolar epithelium of CCSP-Foxm1 / mice. (A–C), Immunohistochemistry was performed in P30 lung sections of
CCSP-Foxm1/ and Foxm1ﬂ/ﬂ mice treated with Dox from E16.5 to P30. Slides were counterstained with nuclear fast red. Arrows show positive staining in CCSP-Foxm1 /
bronchioles (Br). Magniﬁcation: 50 and 400 (insets). (D–G), Transmission electron microscopy (TEM) was used to analyze P30 lung sections. Bronchiolar epithelium in
control mice contained ciliated and Clara cells (D). In the CCSP-Foxm1/ mice, extremely thin, elongated, squamous-like cells (extended lines) were found along the
bronchiolar epithelium, interrupting the normal distribution of Clara (arrowhead) and ciliated cells (arrow) (E). Alveolar type II cells containing mature lamellar bodies
(LBs, arrows and insert in G) were found nestled between adjacent ciliated cells (F–G). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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dramatically altered (Fig. 2A). Extensive regions of the bronch-
ioles lacked the normal cuboidal epithelium seen in control mice
(Fig. 2A and Suppl. Fig. 1B). Bronchioles in CCSP-Foxm1/ lungs
were lined by regions of squamous and cuboidal cells and often
contained cells with enlarged nuclei (Suppl. Fig. 1B).
Clara cells that persisted in the CCSP-Foxm1/ mice expressed
Cre, whereas Cre was not detected in control mice (Suppl. Fig. 2A
and B). Bronchiolar epithelial cells of CCSP-Foxm1/ mice exp-
ressed epithelial cytokeratins and epithelial-speciﬁc transcription
factors TTF-1 and FOXA2 (Suppl. Fig. 2C–E). However, the number of
epithelial cells lining the bronchioles was dramatically reduced
(Suppl. Fig. 2C–E), a result consistent with reduced proliferation of
Clara cells during the early postnatal period (Fig. 1). Expression of
SOX2, a transcription factor critical for proliferation and mainte-
nance of airway epithelium (Que et al., 2009; Tompkins et al., 2009),
was reduced in CCSP-Foxm1/ bronchioles (Suppl. Fig. 2F). Foxm1-
deletion from Clara cells did not inﬂuence the morphology of the
distal lung region. The number of alveolar type II and type I cells was
similar in distal lung regions of CCSP-Foxm1/ and control lungs
(Suppl. Fig. 2G–I). Decreased staining for FOXJ1 and CCSP was
consistent with decreased numbers of ciliated and Clara cells in
CCSP-Foxm1/ bronchioles (Fig. 2B, C and G, H). These results
indicate that Foxm1 is required for proliferation of Clara cells and
normal differentiation of the airway epithelium during the late
embryonic/postnatal period of lung development.
Increased numbers of goblet cells and airway remodeling
in CCSP-Foxm1 / lungs
While goblet cells were not detected in pulmonary bronchioles
of control mice at P30, deletion of Foxm1 dramatically increased
numbers of goblet cells as indicated by staining for Muc5AC
(Fig. 2D) and Alcian blue (Suppl. Fig. 3A). Staining for SPDEF and
FOXA3 transcription factors, associated with goblet cell differen-
tiation (Chen et al., 2009), was increased in CCSP-Foxm1/ mice
(Suppl. Fig. 3B and C). Total numbers of goblet cells were
increased in CCSP-Foxm1/ airways (Fig. 2G and H). E-cadherin
and b-catenin were present in epithelial junctions of control
Foxm1ﬂ/ﬂ bronchioles at P30 (Suppl. Fig. 3E and F). Epithelial
junctions were disrupted in Foxm1-deﬁcient bronchiolar epithe-
lium, causing abnormal localization of E-cadherin and b-catenin
in basal membranes (Suppl. Fig. 3E and F). Increased thickness of
stromal tissue and peribronchiolar ﬁbrosis was observed in most
of the CCSP-Foxm1/ mice (Suppl. Fig. 1B). Consistent with this
ﬁnding, airway resistance in CCSP-Foxm1/ mice was signiﬁ-
cantly induced (Suppl. Fig. 1C), and aSMA staining was increased
(Suppl. Fig. 3D). Thus, loss of Foxm1 in Clara cells inﬂuences
proper epithelial differentiation, causing squamous and goblet
cell metaplasia, and airway remodeling.
Accumulation of alveolar type II cells in bronchioles after deletion
of Foxm1
Bronchioles of CCSP-Foxm1/ mice were lined by extensive
regions of squamous cells expressing T1a (Fig. 2F) that are normally
restricted to alveolar type I cells and a subset of basal cells in the
proximal airway. A subset of bronchiolar epithelial cells in CCSP-
Foxm1/ mice expressed proSP-C, normally a cell-speciﬁc marker
for alveolar type II cells (Fig. 2E). These ectopic type II cells in CCSP-
Foxm1/ bronchioles stained for mature SP-C, mature SP-B and
ABCA3, consistent with differentiated features of normal alveolar
type II cells (Fig. 3A–C). Neither T1a nor type II markers were present
in bronchioles of control mice (Fig. 2E, F and A–C). Approximately 9%
of epithelial cells lining the abnormal CCSP-Foxm1/ bronchioles
were type II cells, whereas squamous cells accounted for 12% of thebronchiolar epithelial cells (Fig. 2G and H). Numbers of cells lining
bronchoalveolar duct junctions that stained for both proSP-C and
CCSP were exceedingly rare and were not altered by deletion of
Foxm1 (Suppl. Fig. 4).
In contrast to bronchiolar epithelium, no squamous or type II
cells were found in the trachea of CCSP-Foxm1/ mice after
morphological examination or immunostaining with cell-speciﬁc
markers (data not shown). Clara cell-speciﬁc markers, CCSP
(Scgb1a1) and Scgb3a1, were reduced in CCSP-Foxm1/ mice
(Suppl. Fig. 5B and G), whereas the numbers and distribution of
basal cells expressing p63 or CK5were not changed (Suppl. Fig. 5C–E).
Co-localization experiments were performed to identify cell types
expressing Foxm1 in tracheal epithelium. In trachea of control
Foxm1ﬂ/ﬂ mice, Foxm1 was detected in CCSP-positive Clara cells
(Suppl. Fig. 5H) and p63-positive basal cells (Suppl. Fig. 5K), as well
as in a rare subset (approximately 1%) of ciliated cells expressing b-
tubulin (Suppl. Fig. 5J). Foxm1 was not found in tracheal goblet cells
(Suppl. Fig. 5I). In CCSP-Foxm1/ trachea, Foxm1 was present in
basal and ciliated cells (Suppl. Fig. 5J and K), but was absent in a
majority of Clara cells (Suppl. Fig. 5H), consistent with Clara cell-
speciﬁc deletion of Foxm1 from tracheal epithelium. Thus, Foxm1
expression in Clara cells is required for development of bronchiolar
(columnar) epithelium but dispensable for development of tracheal
(pseudostratiﬁed) epithelium.
Ultrastructural abnormalities in the bronchioles
of CCSP-Foxm1 / mice
To examine the ultrastructure of CCSP-Foxm1/ bronchioles,
transmission electron microscopy (TEM) was performed at P30.
Squamous epithelium was found in CCSP-Foxm1/ but not in
control bronchioles (Fig. 3D and E). Consistent with the presence of
type II cell markers (Fig. 3A–C), ectopic type II cells were observed
in CCSP-Foxm1/ bronchioles (Fig. 3F–G). Ectopic type II cells
contained lamellar bodies and apical microvilli, and were often
located between ciliated and/or Clara cells in the bronchioles of
CCSP-Foxm1/ mice (Fig. 3F–G). Type II cells were never found in
the conducting airways of control mice (Fig. 3D). The ultrastructural
features of ciliated cells were dramatically altered. Cells with cilia or
Clara cells lacked normal columnar/cuboidal morphology and the
number of cilia on the surface of ciliated cells was reduced (Suppl.
Fig. 6). Abnormal Clara cells contained abundant characteristic
mitochondria but lacked secretory granules (Suppl. Fig. 6D–F).
The ultrastructure of basement membranes was unaltered, how-
ever, the thickness of stromal tissue in the bronchioles was
markedly increased (Suppl. Fig. 6A–F), a ﬁnding consistent with
light microscopic ﬁndings (Suppl. Fig. 1B), and the increased airway
resistance (Suppl. Fig. 1C). Apoptotic cells were not detected in
CCSP-Foxm1/ epithelium by either TEM or immunostaining for
activated caspase 3 (Suppl. Fig. 6 and data not shown).Foxm1 is critical for maintenance of bronchiolar epithelium
and airway structure in the adult lung
Role of Foxm1 in adult airway epithelium was examined in
CCSP-Foxm1/ mice treated with Dox for 5 months. Foxm1
deletion caused extensive peribronchial ﬁbrosis and enlargement
of peripheral respiratory airspaces (Fig. 4A–C). CCSP expression and
numbers of Clara cells were dramatically reduced by the Foxm1
deletion (Fig. 4E). SOX2 immunostaining was decreased (Fig. 4F), a
ﬁnding consistent with diminished SOX2 expression in Foxm1-
deﬁcient lungs at P30 (Suppl. Fig. 2F). Ectopic squamous and type II
cells were detected in the bronchioles of the CCSP-Foxm1/ mice
by immunostaining for T1a, proSP-C and mature SP-C (Fig. 4G–I).
Thus, deletion of Foxm1 from the adult lung, induced peribronchial
Fig. 4. Extended deletion of Foxm1 in Clara cells causes peribronchial ﬁbrosis and accumulation of ectopic type II cells. CCSP-Foxm1/ and control Foxm1ﬂ/ﬂ mice
were treated with Dox until 5 months of age. Lungs were ﬁxed, parafﬁn-embedded, sectioned, and then stained with H&E (A) or trichrome (B). Slides were used for
immunohistochemistry with antibodies speciﬁc to a-smooth muscle actin (C), Cre-recombinase (D), CCSP (E), Sox2 (F), T1a (G), proSP-C (H) and mature SP-C (I). Extended
Dox treatment caused extensive peribronchial ﬁbrosis (A–C) and resulted in accumulation of squamous and type II cells in Foxm1-deﬁcient bronchioles (arrows in G–I).
Decreased CCSP and Sox2 were observed in CCSP-Foxm1/ lungs (E–F). Abbreviation: Br, bronchiole. Magniﬁcations: left columns in A–C, 50; D–F and right columns in
A–C, 400; G–I, 1000.
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accumulation of squamous and type II cells in the bronchiolar
epithelium. A decrease in Clara cells in Foxm1-deﬁcient airways
suggests a reduction in Clara cell proliferation. To directly test
whether Foxm1 induces proliferation of Clara cells in the adult lung,
6–8 weeks old CCSP-Foxm1/ and control Foxm1ﬂ/ﬂ mice were
treated with Dox for 7 day followed by naphthalene administration.
This short Dox treatment was insufﬁcient to disrupt airway
epithelium prior to naphthalene-induced injury (Fig. 5A–D and
data not shown). After injury, proliferation of Clara cells was
reduced in CCSP-Foxm1/ mice compared to controls (Fig. 5F
and J). An increase in the number of epithelial cells expressing
proSP-C and mature SP-C were found in bronchioles of CCSP-
Foxm1/ mice at day 5 (Fig. 5G and H) and day 14 after the injury
(Fig. 5K and L). These results are consistent with a critical role for
Foxm1 in proliferation and differentiation of Clara cells in the
adult lung.
Gene expression proﬁle in CCSP-Foxm1 / lungs
Expression of genes critical for respiratory epithelium was
examined in total RNA from P30 lungs by quantitative real-time
RT-PCR (qRT-PCR). Consistent with increased numbers of goblet
cells, increased mRNA levels of Foxa3 transcription factor were
found in CCSP-Foxm1/ lungs, while Muc5AC mRNA was not
changed (Fig. 6A). While expression of Clara cell transcription
factor Elf3 was increased in CCSP-Foxm1/ lungs, no changes
were found in Ttf1, Foxa2, Spdef and Klf5 (Fig. 6A), all of which are
important transcriptional regulators of gene expression in Clara
cells (Chen et al., 2009; Morrisey and Hogan, 2010; Wan et al.,
2008, 2004). SP-C, SP-B and Abca3mRNAs were increased in CCSP-
Foxm1/ lungs (Fig. 6A), consistent with the increased numbersof mature type II cells in the bronchioles of CCSP-Foxm1/ mice
(Fig. 3). In agreement with these data, increased concentration of
saturated phosphatidylcholine, a main phospholipid of pulmon-
ary surfactant, was found in bronchoalveolar lavage ﬂuid (BALF)
and lung tissue of CCSP-Foxm1/ mice (Suppl. Fig. 1C). There
were no signiﬁcant changes in total or differential counts of
inﬂammatory cells in BALF (Suppl. Fig. 7A and B). Pulmonary
inﬂammation was not observed in CCSP-Foxm1/ lungs by
morphological examination and TEM (data not shown).
Sox2 and CCSP (Scgb1a1) play important roles in differentia-
tion and function of Clara cells (Que et al., 2009; Stripp et al.,
2000; Tompkins et al., 2009). CCSP and Sox2 mRNAs were
signiﬁcantly decreased in CCSP-Foxm1/ lungs (Fig. 6A).
Decreased staining for CCSP and SOX2 was also observed in
CCSP-Foxm1/ lungs at P5 (Fig. 6C), consistent with reduced
expression of these genes at P30 (Fig. 2B and Suppl. Fig. 2F) and at
5 months of age (Fig. 4E and F). Since promoter regions of mouse
Scgb1a1 and Sox2 genes contain potential Foxm1-binding sites
(Fig. 6B), co-transfection experiments were performed to
assess transcriptional regulation of these promoters by Foxm1.
CMV-FoxM1b expression vector increased the activity of the –
2.3 kb Scgb1a1 and the –5.7 kb Sox2 luciferase reporter plasmids
(Fig. 6D). Chromatin Immunoprecipitation (ChIP) assay demon-
strated that endogenous Foxm1 protein speciﬁcally binds to the
promoter regions of Scgb1a1 and Sox2 genes in cultured bronchial
epithelial BEAS-2B cells (Fig. 6E and F). Thus, Foxm1 can function
as a transcriptional activator of Scgb1a1 and Sox2.
Ectopic bronchiolar type II cells are derived from Clara cells
Lineage-tracing experiments were performed to determine
whether ectopic type II cells in CCSP-Foxm1/ airways originated
Fig. 5. Deletion of Foxm1 reduces proliferation of Clara cells after naphthalene-induced lung injury. CCSP-Foxm1 / and control Foxm1ﬂ/ﬂ male mice were treated
with Dox for 7 day followed by naphthalene administration. Mice were sacriﬁced at days 0, 5 and 14 after injury. Lungs were ﬁxed, parafﬁn-embedded, sectioned and used
for immunohistochemistry. After injury, the number of Ki-67-positive Clara cells was reduced in CCSP-Foxm1 / mice compared to controls (F and J). Airway epithelial
cells expressing proSP-C and mature SP-C (mSPC) were found in bronchioles of CCSP-Foxm1 / mice at day 5 (G–H) and day 14 after injury (arrows in K–L). Abbreviation:
Br, bronchiole. Magniﬁcation is 50 and 400 (all inserts).
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CCSP-rtTA/TetO-Cre/Foxm1ﬂ/ﬂ triple-transgenic mice (CCSP-Foxm1ﬂ/ﬂ)
were bred with Rosa26-loxP-STOP-loxP-b-galactosidase reporter
mice (Rosa26R) to generate CCSP-Foxm1//Rosa26R quadruple-
transgenic mice. Mice were provided Dox from E16.5 until P30,
simultaneously inducing Cre-mediated excisions of the Foxm1-ﬂoxed
allele and the LoxP-STOP-LoxP cassette from the Rosa26 locus. Thus,
cells expressing Cre during this period were permanently labeled by
b-galactosidase (b-gal). While b-gal was not detected in control
lungs, cytoplasmic b-gal labeling was observed in CCSP-positive Claracells of CCSP-Foxm1//Rosa26R bronchioles (Fig. 7A). The majority of
ciliated and goblet cells lining CCSP-Foxm1//Rosa26R airways
stained for b-gal (Fig. 7B and C), consistent with previous reports
demonstrating that both ciliated and goblet cells differentiate from
Clara cells (Chen et al., 2009; Rawlins et al., 2009). Neither squamous
epithelial cells nor peribronchial smooth muscle cells in bronchioles
of CCSP-Foxm1//Rosa26Rmice stained for b-gal (7E F). ProSP-C and
b-gal were co-localized in ectopic type II cells (Fig. 7D). Likewise, b-
gal staining was co-localized with ABCA3, mature SP-B and mature
SP-C in bronchioles of CCSP-Foxm1//Rosa26R mice (Fig. 8A, B and
Fig. 6. Foxm1 deletion from Clara cells decreases expression of Sox2 and CCSP in airway epithelium. A, Gene expression proﬁle in CCSP-Foxm1 / lungs. Total lung
mRNA was prepared from CCSP-Foxm1 / and control Foxm1ﬂ/ﬂ mice treated with Dox from E16.5 to P30 and then analyzed by qRT-PCR. B, Schematic drawings of
2.3 kb and 5.7 kb promoter regions of mouse CCSP (Scgb1a1) and Sox2 genes. Locations of potential Foxm1 DNA binding sites are indicated (white boxes).
C, Immunostaining of CCSP-Foxm1/ lungs shows decreased protein expression of CCSP and Sox2 in bronchiolar epithelium at P5. Magniﬁcations: 50 and 400
(inserts). D, Foxm1 induced the transcriptional activity of Scgb1a1 and Sox2 promoters. U2OS cells were transfected with CMV-FoxM1b expression vector and LUC
reporters driven by the Scgb1a1 and Sox2 promoter regions. Dual LUC assays were performed to determine LUC activity (* shows po0.05). E–F, Chromatin
Immunoprecipitation (ChIP) assay was performed in cultured bronchial epithelial BEAS-2B cells. Endogenous Foxm1 protein speciﬁcally binds to the promoter regions
of Scgb1a1 (E) and Sox2 genes (F).
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expressed b-gal reporter (n¼4 mice). Thus, ectopic type II cells were
directly derived from CCSP-expressing cells after deletion of Foxm1,
indicating that airway Clara cells are capable of differentiation into
alveolar type II cells. Foxm1 is required for maintenance of normal
bronchiolar cell differentiation and to restrict differentiation of the
type II cells from conducting airway epithelial cells.Discussion
Foxm1 is critical for differentiation of Clara cells
The important contribution of present study is that Foxm1
regulates progenitor properties of Clara cells in the conducting
airways. Previous studies demonstrated that secretory (Clara)
Fig. 7. Epithelial cells expressing CCSP, FOXJ1, Muc5AC and proSP-C are derived from Clara cells in CCSP-Foxm1 / airways. Rosa26R reporter mice were bred with
CCSP-Foxm1/ mice to generate CCSP-Foxm1//Rosa26R mice. Dox was given E16.5-P30 to label Cre-expressing cells with b-gal. Co-localization experiments were
performed to identify cells expressing b-gal. Cytoplasmic b-gal labeling (arrows) was observed in Clara (A and G), ciliated (B and H), goblet (C) and type II cells (D) of
CCSP-Foxm1//Rosa26R bronchioles (Br) but was not found in control Foxm1ﬂ/ﬂ bronchioles. b-gal did not co-localize with T1a (E) or aSMA (F). Magniﬁcation: (A–F),
2000; (G–H), 400.
V. Ustiyan et al. / Developmental Biology 370 (2012) 198–212208cells in peripheral airways and basal cells in cartilaginous airways
serve as epithelial progenitors that self-renew and give a rise to
various types of airway epithelial cells, including ciliated, goblet
and Clara cells (Rawlins et al., 2009; Rock et al., 2011, 2009).
In the alveolar region, type II epithelial cells have been tradition-
ally viewed as a progenitor cell from which type I and type II cells
are derived following lung injury (Adamson and Bowden, 1974).
While lineage speciﬁcation of epithelial progenitors toward either
conducting airway or alveolar epithelial cells occurs very early in
lung development (Morrisey and Hogan, 2010; Perl et al., 2002), it
is unknown whether airway Clara cells retain the ability to re-
program and differentiate into alveolar type II cells in postnatal
and adult lungs. In present study, proSP-C mRNA and protein
were found in CCSP-Foxm1/ bronchioles. Although proSP-C-
positive cells were detected in airways of mice expressing
activated b-catenin (Mucenski et al., 2005; Reynolds et al.,
2008), highly differentiated type II cells were never found in
conducting airways. The present ultrastructural and gene expres-
sion proﬁling data derived from the CCSP-Foxm1/ bronchioles
were consistent with a fully differentiated phenotype of the type
II cells. These include the presence of cytoplasmic lamellar bodiesand expression of ABCA3, secretion of mature (fully processed)
SP-B and SP-C proteins, as well as increased SatPC in BALF.
Lineage-tracing studies demonstrated that the ectopic type II
cells identiﬁed in the present study were directly derived from
cells in which the Scgb1a1 promoter is selectively active. Our
ﬁndings are surprising and support the concept that Scgb1a1-
expressing cells can acquire structural and functional character-
istics of alveolar type II cells in the developing airways. Given the
robust expression of Foxm1 during the late embryonic/postnatal
period, Foxm1 expression in Clara cell progenitors may be
required to prevent their differentiation into alveolar type II cells.
Previous studies demonstrated that Foxm1 deletion from type
II cells (SPC promoter) causes decreased expression of SPC and
SPB (Kalin et al., 2008). Foxm1 directly binds to promoter regions
of SPC and SPB (Kalin et al., 2008), implicating Foxm1 in tran-
scriptional activation of these genes in type II cells. In contrast to
these studies, SPC and SPB mRNA and protein were increased in
CCSP-Foxm1/ lungs. One explanation for this discrepancy is
that Foxm1 may function as a transcriptional activator of SPC and
SPB in type II cells but repress these genes in Clara cells.
Alternatively, it is possible that Foxm1 may induce expression
Fig. 8. Type II alveolar epithelial cells expressing ABCA3, mature SP-C and mature SP-B are derived from Clara cells in CCSP-Foxm1/ airways. Rosa26-loxP-STOP-loxP-b-
galactosidase reporter mice (Rosa26R) were bred with CCSP-Foxm1/ mice to generate CCSP-Foxm1 //Rosa26R quadruple-transgenic mice. Dox was given E16.5-P30
to label Cre-expressing cells with b-gal. Co-localization experiments were performed to identify cells expressing b-gal. In CCSP-Foxm1 //Rosa26R bronchioles (Br),
cytoplasmic b-gal labeling (arrows) was observed in type II cells expressing ABCA3 (A), mature SP-C (B) and mature SP-B (C). Neither b-gal nor type II marker proteins were
found in bronchioles of control Foxm1ﬂ/ﬂ/Rosa26R mice. Magniﬁcation is 2000.
V. Ustiyan et al. / Developmental Biology 370 (2012) 198–212 209of a Clara cell-speciﬁc transcriptional repressor(s), which directly
inhibits SPC and SPB in Clara cells. In the absence of Foxm1,
transcriptional repression of these genes is relieved, possibly
contributing to increased SPB and SPC levels in a subset of airway
Clara cells. Consistent with this hypothesis, Foxm1 was shown to
differentially regulate many genes depending on tissue-speciﬁ-
city, developmental stage and biological context (reviewed in
(Kalin et al., 2011)).Foxm1 induces proliferation of Clara cells
In the present study, cell proliferation and decreased numbers
of epithelial cells were observed in CCSP-Foxm1/ airways
during postnatal lung development and naphthalene-induced
lung injury. In support of the role of Foxm1 in the regulation of
cell proliferation, previous studies demonstrated that Foxm1
directly activates transcription of multiple cell cycle regulatory
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cultured tumor cells and mouse embryonic ﬁbroblasts (MEFs)
(Costa et al., 2003, 2005; Laoukili et al., 2005; Wang et al., 2005).
Expression of Foxm1 in vivo accelerated cellular proliferation
during tissue regeneration/repair and tumor formation (Kalin
et al., 2006; Kalinichenko et al., 2003, 2004b; Wang et al.,
2008). However, no proliferative defects were found in the
respiratory epithelium of either Foxm1/ embryos (Kim et al.,
2005b) or SP-C-rtTA/TetO-Cre/Foxm1/ embryos (Kalin et al.,
2008) at E15.5. Thus, Foxm1 is not required for proliferation of
embryonic lung epithelium but is critical for proliferation of Clara
cells after birth, ﬁndings consistent with increased proliferation of
Clara cells and severe airway hyperplasia found in transgenic
mice expressing activated FoxM1 mutant (Wang et al., 2010).
Foxm1 is critical for long-term maintenance of bronchiolar
epithelium
In the present study, we found that long-term deletion of
Foxm1 disrupted airway structure, caused peribronchial ﬁbrosis
and resulted in accumulation of ectopic type II cells in bronchioles
of adult CCSP-Foxm1/ mice. In contrast, the ﬁbrosis and ectopic
type II cells were not found two weeks after targeted deletion of
Foxm1 in the airways (data not shown). Thus, Foxm1 is required
for maintenance of airway epithelial differentiation and its loss
did not cause rapid trans-differentiation of existing Clara cells
into type II cells. These ﬁndings support the role of Foxm1 in self-
renewal of airway epithelium. Increased airway resistance and
peribronchial ﬁbrosis seen in CCSP-Foxm1/ mice are likely
indirect consequences of airway epithelial defects caused by
Foxm1 deletion. Since no signiﬁcant changes in numbers of
inﬂammatory cells were found in BALF of CCSP-Foxm1/ mice,
it is unlikely that pulmonary inﬂammation plays a role in the
development of peribronchial ﬁbrosis in CCSP-Foxm1/ mice.
Although our lineage-tracing studies ruled out EMT in
Foxm1-deﬁcient airway epithelial cells, Foxm1 deletion may
inﬂuence epithelial homeostasis and/or cell-to-cell contacts in
CCSP-Foxm1/ airways, resulting in activation and proliferation
of peribronchial ﬁbroblasts and smooth muscle cells.
Foxm1 deletion from Clara cells does not inﬂuence tracheal
epithelium
Our lineage-tracing studies demonstrated that squamous cells
expressing T1a in the bronchioles of Foxm1-deﬁcient mice did
not originate from Scgb1a1-expressing cells. Although the origin
of squamous cells in CCSP-Foxm1/ bronchioles remains unclear,
previous studies demonstrated that a rare population of cells
in bronchio-alveolar duct junctions (BASCs) can differentiate
toward alveolar epithelial lineages under experimental condi-
tions (Kim et al., 2005a; Nolen-Walston et al., 2008). Recent studies
demonstrated that alveolar epithelial cells may also originate
from a6b4-expressing cells that can serve as a multipotent epithe-
lial progenitor during lung repair (Chapman et al., 2011). The
ﬁnding that neither type II nor squamous cells were found in
CCSP-Foxm1/ trachea suggest that Foxm1 deletion did not result
in re-programming of tracheal Clara cells. It is unlikely that this
was due to inefﬁcient Foxm1 deletion because robust Cre stain-
ing and reduced numbers of Clara cells were found in trachea of
CCSP-Foxm1/ mice. Since lineage-tracing studies demonstrated
that the cell progenitors are distinct in trachea vs. epithelium from
the peripheral lung (Perl et al., 2002), it is possible that Foxm1
requirements in tracheal and bronchiolar Clara cells are distinct.
Alternatively, different genes can restrict differentiation of the Clara
cell subtypes. Since the tracheal-bronchial epithelium is lined by a
pseudostratiﬁed epithelium that includes basal cells, that are nottargeted by Scgb1a1 promoter used in the present study, these non-
targeted cells may serve as a source of the T1aþ cells that were seen
in the airways of Foxm1-deﬁcient mice. Basal cells are known to
serve as progenitor cells from which both Clara and ciliated cells are
derived in the proximal airways (Rock et al., 2011, 2009; Whitsett
and Kalinichenko, 2011). Therefore, basal cells are likely to com-
pensate for the loss of Scgb1a1-positive progenitor cells, contribut-
ing to maintenance of tracheal epithelium in CCSP-Foxm1/ mice.
Foxm1 regulates expression of Sox2
Deletion of Foxm1 was associated with reduced Sox2 expres-
sion in the bronchiolar epithelium. Deletion of Sox2 from Clara
cells inhibited proliferation, decreased the numbers of bronchio-
lar epithelial cells, caused squamous metaplasia and prevented
differentiation of Clara, ciliated and goblet cells (Que et al., 2009;
Tompkins et al., 2009), ﬁndings similar to some of those in CCSP-
Foxm1/ mice. Thus, the loss of Sox2, a gene critical for
differentiation of conducting airway epithelial cells, may contri-
bute to the loss of normal epithelial cells after deletion of Foxm1.
While decreased Sox2 mRNA may be related in part to reduced
numbers of epithelial cells in CCSP-Foxm1/ airways, immuno-
histochemistry demonstrated reduced intensity of Sox2 staining
in bronchioles. The ﬁnding that Foxm1 induced the Sox2 promoter
activity in vitro further supports a potential role of Foxm1 in the
regulation of Sox2 gene. Previous studies did not observe alveolar
cells in bronchiolar epithelium of Sox2-deﬁcient mice (Tompkins
et al., 2009), indicating that Sox2 and Foxm1 play distinct roles in
airway epithelial cell differentiation.
Summary and signiﬁcance
Deletion of Foxm1 from bronchiolar Clara cells decreased
proliferation and dramatically altered the cellular composition of
the bronchiolar epithelium. Ectopic differentiation of type II
alveolar cells in the bronchioles of CCSP-Foxm1/ mice indicates
that Foxm1 plays a critical role in the differentiation and main-
tenance of proximal vs. peripheral respiratory epithelial cell fate in
the perinatal and adult lung. These studies demonstrate that Clara
cells are capable of re-differentiation into alveolar type II cells in
the absence of Foxm1 and that alveolar type II cells are not fully
restricted from conducting airway epithelial fate by extrinsic
cellular and intracellular cues. In summary, Foxm1 plays a critical
role in the regulation of gene expression required for the restriction
of bronchiolar cells to conducting vs. alveolar regions of the lung.Acknowledgments
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